在CEPI中央实验室网络中监测免疫学COVID-19疫苗临床试验
Lauren M Schwartz1, Jose Vila-Belda1, Jerome Carless1
1Gorman Consulting, Edmonds, WA, United States.
Frontiers in immunology
|April 18, 2025
概括
CEPI - 中央化实验室网络 (CLN) 开发了一个强大的数据系统,用于跟踪超过70,000个SARS-CoV-2疫苗临床样本. 该系统确保了数据的准确性,并促进了分析,以便在疫苗开发中做出明智的决策.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 数据科学数据科学数据科学
背景情况:
- 疫情准备创新联盟 (CEPI) -中央实验室网络 (CLN) 在SARS-CoV-2疫苗开发中发挥了关键作用.
- 超过7万个临床样本在多个疫苗开发商中进行了测试.
研究的目的:
- 描述CEPI-CLN为临床样本测试开发的集中数据管理系统.
- 突出系统在确保数据质量,准确性和促进疫苗开发分析方面的作用.
主要方法:
- 开发一个集中的数据管理系统,内置数据质量检查.
- 通过自动统计验证,安全提交测试设施的结果.
- 专家审查报告,并将其整合到关系数据库中进行分析.
主要成果:
- 该系统成功管理和处理了超过7万个临床样本,用于SARS-CoV-2疫苗开发.
- 数据质量检查和专家审查确保了免疫学结果的准确性和完整性.
- 交互式仪表板可视化控制趋势和样本结果,帮助数据协调.
结论:
- CEPI-CLN数据管理系统在确保免疫学数据质量和支持疫苗开发方面是有效的.
- 该系统对SARS-CoV-2的成功将扩展到新的病原体和测试.
- 统一的免疫学数据分析为CEPI的战略决策提供了信息.
更多相关视频
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.7K
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
906
相关概念视频
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...